Aktienanalyse zu Gentherm Inc (THRM)THRMGentherm Inc

Gentherm Incorporated is a provider of thermal and precision flow management technologies. The Automotive reporting segment comprises global automotive businesses, including the design, development, manufacturing and sales of its automotive climate and comfort solutions (including Climate Control Seats, Climate Control Interiors, and others), Valve Systems and other automotive products. The Medical reporting segment comprises the patient temperature management business in the medical industry. Patient temperature management includes temperature management systems across multiple product categories addressing the needs of hyper-hypothermia therapy in intensive care, normothermia in surgical procedures and additional warming/cooling therapies utilized in acute and chronic care departments and non-hospital facilities. It also offers highly engineered, mission-critical thermal solutions serving commercial vehicles, off-highway equipment, light vehicle and power generation markets. It operates in the Consumer Cyclicals sector (MOTOR VEHICLE PARTS & ACCESSORIES industry).

Gentherm Inc (THRM) is currently priced at $29.04, which is significantly below the analyst price target of $48 from JPMorgan, indicating a potential upside of approximately 65%. However, the stock has a low RSI of 24.39, suggesting it is oversold, but the recent trend shows a 20.11% decline over the last 20 days, indicating ongoing weakness. The significant increase in hedge fund selling by 8556.93% raises concerns about market sentiment. Therefore, while there is potential for recovery, the risks are substantial and a hold is recommended for now.

9 analysts cover THRM: 5 rate it Buy, 4 Hold and 0 Sell. The average price target is 43.33.